Literature DB >> 24036496

Liver X receptor activation stimulates iron export in human alternative macrophages.

Gaël Bories1, Sophie Colin, Jonathan Vanhoutte, Bruno Derudas, Corinne Copin, Mélanie Fanchon, Mehdi Daoudi, Loïc Belloy, Stephan Haulon, Christophe Zawadzki, Brigitte Jude, Bart Staels, Giulia Chinetti-Gbaguidi.   

Abstract

RATIONALE: In atherosclerotic plaques, iron preferentially accumulates in macrophages where it can exert pro-oxidant activities.
OBJECTIVE: The objective of this study was, first, to better characterize the iron distribution and metabolism in macrophage subpopulations in human atherosclerotic plaques and, second, to determine whether iron homeostasis is under the control of nuclear receptors, such as the liver X receptors (LXRs). METHODS AND
RESULTS: Here we report that iron depots accumulate in human atherosclerotic plaque areas enriched in CD68 and mannose receptor (MR)-positive (CD68(+)MR(+)) alternative M2 macrophages. In vitro IL-4 polarization of human monocytes into M2 macrophages also resulted in a gene expression profile and phenotype favoring iron accumulation. However, M2 macrophages on iron exposure acquire a phenotype favoring iron release, through a strong increase in ferroportin expression, illustrated by a more avid oxidation of extracellular low-density lipoprotein by iron-loaded M2 macrophages. In line, in human atherosclerotic plaques, CD68(+)MR(+) macrophages accumulate oxidized lipids, which activate LXRα and LXRβ, resulting in the induction of ABCA1, ABCG1, and apolipoprotein E expression. Moreover, in iron-loaded M2 macrophages, LXR activation induces nuclear factor erythroid 2-like 2 expression, thereby increasing ferroportin expression, which, together with a decrease of hepcidin mRNA levels, promotes iron export.
CONCLUSIONS: These data identify a role for M2 macrophages in iron handling, a process regulated by LXR activation.

Entities:  

Keywords:  atherosclerosis; iron; macrophages; receptors, cytoplasmic and nuclear

Mesh:

Substances:

Year:  2013        PMID: 24036496      PMCID: PMC3989231          DOI: 10.1161/CIRCRESAHA.113.301656

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  36 in total

1.  Low density lipoprotein undergoes oxidation within lysosomes in cells.

Authors:  Yichuan Wen; David S Leake
Journal:  Circ Res       Date:  2007-04-19       Impact factor: 17.367

2.  PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.

Authors:  M Amine Bouhlel; Bruno Derudas; Elena Rigamonti; Rébecca Dièvart; John Brozek; Stéphan Haulon; Christophe Zawadzki; Brigitte Jude; Gérard Torpier; Nikolaus Marx; Bart Staels; Giulia Chinetti-Gbaguidi
Journal:  Cell Metab       Date:  2007-08       Impact factor: 27.287

3.  Impact of heme oxygenase-1 on cholesterol synthesis, cholesterol efflux and oxysterol formation in cultured astroglia.

Authors:  Jacob R Hascalovici; Wei Song; Jacob Vaya; Soliman Khatib; Bianca Fuhrman; Michael Aviram; Hyman M Schipper
Journal:  J Neurochem       Date:  2008-11-15       Impact factor: 5.372

4.  Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques.

Authors:  Domenico Lapenna; Sante D Pierdomenico; Giuliano Ciofani; Sante Ucchino; Matteo Neri; Maria Adele Giamberardino; Franco Cuccurullo
Journal:  Free Radic Biol Med       Date:  2006-11-17       Impact factor: 7.376

5.  Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype.

Authors:  Joseph J Boyle; Heather A Harrington; Emma Piper; Kay Elderfield; Jaroslav Stark; Robert C Landis; Dorian O Haskard
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

Review 6.  Liver X receptor in cholesterol metabolism.

Authors:  Chunyan Zhao; Karin Dahlman-Wright
Journal:  J Endocrinol       Date:  2009-10-16       Impact factor: 4.286

7.  Intraplaque hemorrhage and progression of coronary atheroma.

Authors:  Frank D Kolodgie; Herman K Gold; Allen P Burke; David R Fowler; Howard S Kruth; Deena K Weber; Andrew Farb; L J Guerrero; Motoya Hayase; Robert Kutys; Jagat Narula; Aloke V Finn; Renu Virmani
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

8.  Overexpression of transferrin receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques.

Authors:  Wei Li; Li-Hua Xu; Claes Forssell; Jerome L Sullivan; Xi-Ming Yuan
Journal:  Exp Biol Med (Maywood)       Date:  2008-04-29

Review 9.  The iron hypothesis of atherosclerosis and its clinical impact.

Authors:  Xi-Ming Yuan; Wei Li
Journal:  Ann Med       Date:  2003       Impact factor: 4.709

10.  Differential regulation of iron homeostasis during human macrophage polarized activation.

Authors:  Stefania Recalcati; Massimo Locati; Agnese Marini; Paolo Santambrogio; Federica Zaninotto; Maria De Pizzol; Luca Zammataro; Domenico Girelli; Gaetano Cairo
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

View more
  37 in total

Review 1.  Macrophage subsets in atherosclerosis.

Authors:  Giulia Chinetti-Gbaguidi; Sophie Colin; Bart Staels
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

Review 2.  Macrophage-Targeted Therapeutics for Metabolic Disease.

Authors:  Kristin R Peterson; Matthew A Cottam; Arion J Kennedy; Alyssa H Hasty
Journal:  Trends Pharmacol Sci       Date:  2018-04-05       Impact factor: 14.819

Review 3.  Use of Primary Macrophages for Searching Novel Immunocorrectors.

Authors:  Nikita G Nikiforov; Natalia V Elizova; Michael Bukrinsky; Larisa Dubrovsky; Vsevolod J Makeev; Yoshiyuki Wakabayashi; Poching Liu; Kathy K Foxx; Howard S Kruth; Xueting Jin; Emile R Zakiev; Alexander N Orekhov
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 4.  Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy.

Authors:  Amir Abbas Momtazi-Borojeni; Elham Abdollahi; Banafsheh Nikfar; Shahla Chaichian; Mahnaz Ekhlasi-Hundrieser
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214

5.  Vessel-associated myogenic precursors control macrophage activation and clearance of apoptotic cells.

Authors:  L Bosurgi; S Brunelli; E Rigamonti; A Monno; A A Manfredi; P Rovere-Querini
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

6.  Hepcidin Deficiency Protects Against Atherosclerosis.

Authors:  Rajeev Malhotra; Florian Wunderer; Hanna J Barnes; Aranya Bagchi; Mary D Buswell; Caitlin D O'Rourke; Charles L Slocum; Clara D Ledsky; Kathryn M Peneyra; Haakon Sigurslid; Benjamin Corman; Kimberly B Johansson; David K Rhee; Kenneth D Bloch; Donald B Bloch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

7.  MFehi adipose tissue macrophages compensate for tissue iron perturbations in mice.

Authors:  Merla J Hubler; Keith M Erikson; Arion J Kennedy; Alyssa H Hasty
Journal:  Am J Physiol Cell Physiol       Date:  2018-05-16       Impact factor: 4.249

8.  Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2.

Authors:  Xiaoyan Yang; Seong-Hoon Park; Hsiang-Chun Chang; Jason S Shapiro; Athanassios Vassilopoulos; Konrad T Sawicki; Chunlei Chen; Meng Shang; Paul W Burridge; Conrad L Epting; Lisa D Wilsbacher; Supak Jenkitkasemwong; Mitchell Knutson; David Gius; Hossein Ardehali
Journal:  J Clin Invest       Date:  2017-03-13       Impact factor: 14.808

Review 9.  Regulation of tissue iron homeostasis: the macrophage "ferrostat".

Authors:  Nathan C Winn; Katrina M Volk; Alyssa H Hasty
Journal:  JCI Insight       Date:  2020-01-30

Review 10.  The role of hepcidin and iron homeostasis in atherosclerosis.

Authors:  Florian Wunderer; Lisa Traeger; Haakon H Sigurslid; Patrick Meybohm; Donald B Bloch; Rajeev Malhotra
Journal:  Pharmacol Res       Date:  2020-01-25       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.